TCL Archive Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer September 26, 2008
TCL Archive Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million January 19, 1979
TCL Archive Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial June 12, 1992